BusinessPernix Therapeutics to Present at Needham & Company’s 15th Annual Healthcare ConferenceBy Nasdaq OMXApr 5, 2016, 8:01 PM UTC
BusinessPernix Therapeutics Files Citizen Petition Following Issuance of U.S. Patent Number 9,265,760 (‘760 Patent) Covering Safety Information Related to Dosing Patients with Zohydro ER® with BeadTek™ CIIBy Nasdaq OMXMar 2, 2016, 1:30 PM UTC
BusinessPernix Therapeutics to Report Fourth Quarter and Full-Year 2015 Financial Results on Thursday, March 10, 2016By Nasdaq OMXFeb 24, 2016, 1:44 PM UTC
